103 related articles for article (PubMed ID: 21267493)
1. Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF.
Wisastra R; Ghizzoni M; Maarsingh H; Minnaard AJ; Haisma HJ; Dekker FJ
Org Biomol Chem; 2011 Mar; 9(6):1817-22. PubMed ID: 21267493
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.
Ghizzoni M; Haisma HJ; Dekker FJ
Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones.
Dekker FJ; Ghizzoni M; van der Meer N; Wisastra R; Haisma HJ
Bioorg Med Chem; 2009 Jan; 17(2):460-6. PubMed ID: 19111471
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
6. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Groutas WC; Chong LS; Venkataraman R
Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
[TBL] [Abstract][Full Text] [Related]
7. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cathepsin B activity by cysteine and related thiols.
Krepela E; Procházka J; Kárová B
Biol Chem; 1999 May; 380(5):541-51. PubMed ID: 10384960
[TBL] [Abstract][Full Text] [Related]
9. Natural biflavones as novel inhibitors of cathepsin B and K.
Zeng GZ; Pan XL; Tan NH; Xiong J; Zhang YM
Eur J Med Chem; 2006 Nov; 41(11):1247-52. PubMed ID: 16828525
[TBL] [Abstract][Full Text] [Related]
10. Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis.
Lim IT; Meroueh SO; Lee M; Heeg MJ; Mobashery S
J Am Chem Soc; 2004 Aug; 126(33):10271-7. PubMed ID: 15315439
[TBL] [Abstract][Full Text] [Related]
11. Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.
Sosič I; Mirković B; Turk S; Štefaneb B; Kos J; Gobec S
Eur J Med Chem; 2011 Sep; 46(9):4648-56. PubMed ID: 21849222
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
13. Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach.
Suryanarayanan V; Singh SK
J Recept Signal Transduct Res; 2015; 35(5):370-80. PubMed ID: 25404235
[TBL] [Abstract][Full Text] [Related]
14. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
[TBL] [Abstract][Full Text] [Related]
15. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
[TBL] [Abstract][Full Text] [Related]
16. Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Eur J Med Chem; 2014 Apr; 77():231-42. PubMed ID: 24642566
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids.
Park WJ; Ma E
Arch Pharm Res; 2012 Aug; 35(8):1379-86. PubMed ID: 22941480
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules.
Arif M; Pradhan SK; Thanuja GR; Vedamurthy BM; Agrawal S; Dasgupta D; Kundu TK
J Med Chem; 2009 Jan; 52(2):267-77. PubMed ID: 19086895
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
20. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.
Casini A; Gabbiani C; Sorrentino F; Rigobello MP; Bindoli A; Geldbach TJ; Marrone A; Re N; Hartinger CG; Dyson PJ; Messori L
J Med Chem; 2008 Nov; 51(21):6773-81. PubMed ID: 18834187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
